Bonyf NV | Finanzwire

BRIEF

published on 06/07/2024 at 17:18, 5 months 15 days ago

Proven Efficacy of Bonyf's Fast Pain-Relief Mouth Ulcer Cream

Bonyf Mouth Ulcer Research & Development AphtoFix
PRESS RELEASE

published on 06/07/2024 at 17:13, 5 months 15 days ago

Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream
bonyf NV reaffirms commitment to R&D and showcases proven efficacy of fast pain-relief mouth ulcer cream AphtoFix® through recent clinical study. Company focuses on advancing oral healthcare with innovative solutions

R&D Clinical Study Bonyf NV Mouth Ulcer Cream Oral Healthcare
BRIEF

published on 05/10/2024 at 15:10, 6 months 12 days ago

Bonyf NV Anticipates Record Breaking Growth in 2024

Bonyf NV 2024 Sales Forecast Oral Hygiene Products MDR Compliance Contract Manufacturing
PRESS RELEASE

published on 05/10/2024 at 15:05, 6 months 12 days ago

2024 Sales Forecast: Unprecedented Growth on the Horizon
bonyf NV (MLBON) expects unprecedented sales growth in 2024, leveraging compliance with European Medical Device Regulation and unique product offerings

Sales Forecast Bonyf NV Oral Hygiene Products Unprecedented Growth European MDR
BRIEF

published on 04/16/2024 at 15:24, 7 months 6 days ago

Bonyf Set to Exhibit at PLMA Amsterdam in May 2024

Euronext Paris PLMA Amsterdam 2024 Bonyf NV Oral Care Products Medical Device Regulation
PRESS RELEASE

published on 04/16/2024 at 15:19, 7 months 6 days ago

bonyf exhibits at PLMA Amsterdam on 28-29 May 2024
bonyf NV, a Euronext Paris listed company specializing in oral comfort products, announces expansion of clientele due to successful PLMA Amsterdam exhibition participation. Company highlights products with patented formulations, proven clinical efficacy, and commercial presence in 37 countries

Bonyf NV Oral Care Products Medical Device Regulation Oral Comfort PLMA Amsterdam
BRIEF

published on 04/04/2024 at 18:22, 7 months 18 days ago

Bonyf Advances to Phase 2 in Development of its Alginate-Organic Denture Fixative Cream

Bonyf Alginate-Organic Denture Fixative Cream Phase 2 Development Oral Care Innovation Denture Care
PRESS RELEASE

published on 04/04/2024 at 18:17, 7 months 18 days ago

bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream
bonyf advances to Phase 2 in the development of Alginate-Organic Denture Fixative Cream, aiming for superior grip and comfort for denture wearers. Company strives for innovation and excellence in oral care

Innovation Phase 2 Bonyf Alginate-Organic Denture Fixative Cream Oral Care
PRESS RELEASE

published on 07/20/2023 at 18:00, 1 year 4 months ago

bonyf NV: bonyf’s 2022 financial statements made available
PRESS RELEASE

published on 06/30/2023 at 14:35, 1 year 4 months ago

bonyf NV: Delay in release of financial statements 2022

Published on 11/22/2024 at 23:55, 9 hours 23 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 48 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 13 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 10 hours 13 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 48 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 15 hours 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 15 hours 18 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 15 hours 24 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 22 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 17 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 18 hours 42 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News